• OPEN AN ACCOUNT
Indian Indices
Sensex
83,570.35 187.64
( 0.23%)
Global Indices
Nasdaq
49,379.59 -83.86
(-0.17%)
Dow Jones
6,960.70 -4.77
(-0.07%)
Hang Seng
53,996.71 -113.79
(-0.21%)
Nikkei 225
10,219.48 -19.46
(-0.19%)
Forex
USD-INR
90.32 0.07
(0.08%)
EUR-INR
104.98 -0.13
(-0.12%)
GBP-INR
121.10 -0.20
(-0.16%)
JPY-INR
0.57 0.00
(0.21%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
37.0210703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
235.76
277.67
EPS(TTM)
Face Value()
Div & Yield %
0.33
10
0
 
( Cr)
ParticularsSep 2025 ( Cr)Jun 2025 ( Cr)Mar 2025 ( Cr)
Gross Sales32.9729.1830.52
Other Operating Income0.000.000.00
Other Income 1.210.670.72
Total Income34.1929.8431.24
Total Expenditure 36.1225.7927.11
PBIDT-1.944.064.13
Interest 0.790.850.52
PBDT-2.733.203.61
Depreciation2.072.031.34
Tax0.180.310.62
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.350.050.35
Reported Profit After Tax-3.630.811.31
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-3.630.811.31
EPS (Unit Curr.)-1.020.220.36
EPS (Adj) (Unit Curr.)-1.020.220.36
Calculated EPS (Unit Curr.)-1.020.230.37
Calculated EPS (Adj) (Unit Curr.)-1.020.230.37
Calculated EPS (Ann.) (Unit Curr.)-4.060.911.46
Calculated EPS (Adj) (Ann.) (Unit Curr.)-4.060.911.46
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity35.6935.6935.69
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-5.8813.9113.53
PBDTM(%)-8.2810.9711.83
PATM(%)-11.012.784.29